DUSP5 and urinary bladder carcinoma: Compound 27 effectively modulates the p38 MAPK signaling pathway by stably binding to DUSP5 and promotes cell apoptosis by upregulating the expression level of DUSP5, thereby inhibiting the occurrence and development of bladder cancer.